All Knowledge & Insights By Date

On September 17, 2020, the European Alliance for Access to Safe Medicines (EAASM) announced the availability of a report entitled Patient Safety and Nanomedicines:  The need for a centralised regulatory procedure.  According to EAASM, “[n]anomedicines and their follow-on products, also referred to as nanosimilars, are complex molecules and so regulatory oversight must be scientifically fit for purpose.”  The report makes three key recommendations intended to...

On March 7, 2018, the Nanotechnology Industries Association (NIA) will hold a webinar on “Nanomedicine:  Diagnostics and therapeutics advancing through nanotechnology.”  The webinar will focus on the diagnostic and therapeutic applications of nanotechnology, with the agenda including: Regulatory landscape in Europe and beyond for nanomaterials in healthcare applications; and Industry developments within nanomedicine from NIA Members: Endomag — A United Kingdom/U.S. small- or...